Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
19433311
DOI
10.1016/j.biocel.2009.02.015
PII: S1357-2725(09)00085-5
Knihovny.cz E-resources
- MeSH
- Antioxidants metabolism MeSH
- Cell Respiration drug effects MeSH
- Glucose pharmacology MeSH
- Mitochondria, Liver drug effects metabolism MeSH
- Rats MeSH
- Humans MeSH
- Mitochondria drug effects metabolism MeSH
- Cell Line, Tumor MeSH
- Oxidative Phosphorylation drug effects MeSH
- Hydrogen Peroxide metabolism MeSH
- Proton Pumps metabolism MeSH
- Reactive Oxygen Species metabolism MeSH
- Electron Transport Complex I metabolism MeSH
- Electron Transport Complex II metabolism MeSH
- Electron Transport Complex III metabolism MeSH
- Rotenone pharmacology MeSH
- Oxygen Consumption drug effects MeSH
- Superoxides metabolism MeSH
- Electron Transport drug effects MeSH
- Ubiquinone analogs & derivatives metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antioxidants MeSH
- coenzyme Q10 MeSH Browser
- Glucose MeSH
- Hydrogen Peroxide MeSH
- Proton Pumps MeSH
- Reactive Oxygen Species MeSH
- Electron Transport Complex I MeSH
- Electron Transport Complex II MeSH
- Electron Transport Complex III MeSH
- Rotenone MeSH
- Superoxides MeSH
- Ubiquinone MeSH
Oxidative stress of mitochondrial origin, i.e. elevated mitochondrial superoxide production, belongs to major factors determining aging and oxidative-stress-related diseases. Antioxidants, such as the mitochondria-targeted coenzyme Q, MitoQ(10), may prevent or cure these pathological conditions. To elucidate pro- and anti-oxidant action of MitoQ(10), we studied its effects on HepG2 cell respiration, mitochondrial network morphology, and rates of superoxide release (above that neutralized by superoxide dismutase) to the mitochondrial matrix (J(m)). MitoSOX Red fluorescence confocal microscopy monitoring of J(m) rates showed pro-oxidant effects of 3.5-fold increased J(m) with MitoQ(10). MitoQ(10) induced fission of the mitochondrial network which was recovered after 24h. In rotenone-inhibited HepG2 cells (i.e., already under oxidative stress) MitoQ(10) sharply decreased rotenone-induced J(m), but not together with the Complex II inhibitor thenoyltrifluoroacetone. Respiration of HepG2 cells and isolated rat liver mitochondria with MitoQ(10) increased independently of rotenone. The increase was prevented by thenoyltrifluoroacetone. These results suggest that MitoQ(10) accepts electrons prior to the rotenone-bound Q-site, and the Complex II reverse mode oxidizes MitoQ(10)H(2) to regenerate MitoQ(10). Consequently, MitoQ(10) has a pro-oxidant role in intact cells, whereas it serves as an antioxidant when Complex I-derived superoxide generation is already elevated due to electron flow retardation. Moreover, unlike mitochondrial uncoupling, MitoQ(10) exerted its antioxidant role when Complex I proton pumping was retarded by a hydrophobic amiloride, 5-(N-ethyl-N-isopropyl) amiloride. Consequently, MitoQ(10) may be useful in the treatment of diseases originating from impairment of respiratory chain Complex I due to oxidatively damaged mitochondrial DNA, when its targeted delivery to pathogenic tissues is ensured.
References provided by Crossref.org
Potential of Mitochondria-Targeted Antioxidants to Prevent Oxidative Stress in Pancreatic β-cells